Stock QLIFE QLIFE HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Qlife Holding AB Stock

Equities

QLIFE

SE0013486552

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:55 2024-04-19 am EDT 		5-day change 1st Jan Change
0.0035 SEK +6.06% Intraday chart for Qlife Holding AB +12.90% -82.41%
Apr. 05 Qlife Places Danish Operational Company in Reconstruction Mode MT
Mar. 25 Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership MT

Financials

Sales 2023 244K 22.35K Sales 2024 * 3M 275K Capitalization 2.26M 207K
Net income 2023 * - Net income 2024 * - EV / Sales 2023 103 x
Net cash position 2023 12.39M 1.13M Net cash position 2024 * - 0 EV / Sales 2024 * 0.75 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees 13
Yield 2023 *
-
Yield 2024 *
-
Free-Float 96.41%
More Fundamentals * Assessed data

Chart Qlife Holding AB

Dynamic Chart

Latest news about Qlife Holding AB

Qlife Places Danish Operational Company in Reconstruction Mode MT
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership MT
Qlife Signs Letter of Intent with Precision Biosensor CI
Qlife Secures Core Patent for Egoo System in EU, UK Markets MT
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom CI
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology CI
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024 CI
Qlife Enters Collaboration Agreement with Hipro Biotechnology CI
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar MT
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Qlife Secures Chinese Partner for Egoo Health; Stock Surges 44% MT
Qlife Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Qlife Holding AB announced that it has received SEK 4.647035 million in funding from Pensys Ab, Jinderman & Partners AB CI
More news

Press releases Qlife Holding AB

Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure AQ
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships AQ
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans. AQ
Qlife publishes prospectus due to upcoming rights issue of units AQ
Bulletin from the extraordinary general meeting in Qlife Holding AB on 16 January 2024 AQ
More press releases

Quotes and Performance

1 day+6.06%
1 week+12.90%
Current month-67.89%
1 month-69.83%
3 months-77.56%
6 months-90.00%
Current year-82.41%
More quotes

Highs and lows

1 week
0.00
Extreme 0.0028
0.00
1 month
0.00
Extreme 0.0028
0.02
Current year
0.00
Extreme 0.0028
0.02
1 year
0.00
Extreme 0.0028
0.50
3 years
0.00
Extreme 0.0028
51.00
5 years
0.00
Extreme 0.0028
60.00
10 years
0.00
Extreme 0.0028
60.00
More quotes

Managers and Directors - Qlife Holding AB

Managers TitleAgeSince
Peter Warthoe FOU
 Founder 57 18-12-31
Thomas Warthoe FOU
 Founder 57 19-10-10
Peter Thorsen DFI
 Director of Finance/CFO 58 Oct. 31
Members of the board TitleAgeSince
Thomas Warthoe FOU
 Founder 57 19-10-10
Lars Bangsgaard CHM
 Chairman 71 22-12-31
Lars Wegner BRD
 Director/Board Member 49 22-12-31
More insiders

Quotes

Date Price Change Volume
24-04-19 0.0035 +6.06% 42,463,780
24-04-18 0.0033 +3.12% 31,204,490
24-04-17 0.0032 +6.67% 36,192,250
24-04-16 0.003 -6.25% 26,274,860
24-04-15 0.0032 +3.23% 40,575,700

Delayed Quote Nasdaq Stockholm, April 19, 2024 at 11:29 am EDT

More quotes

Company Profile

Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-06 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
QLIFE HOLDING AB Stock Qlife Holding AB
-82.41% 195K
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.53% 183B
MEDTRONIC PLC Stock Medtronic plc
-3.52% 105B
DEXCOM, INC. Stock DexCom, Inc.
+5.33% 51.77B
CENCORA, INC. Stock Cencora, Inc.
+16.43% 47.29B
HOYA CORPORATION Stock Hoya Corporation
-1.73% 40.2B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+5.66% 27.62B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
-2.01% 25.51B
TERUMO CORPORATION Stock Terumo Corporation
+9.84% 24.73B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.87% 24.52B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. QLIFE Stock